Haderer Marika, Hofmann Reiner, Bartelmeß Tina, König Laura, Betz Constanze, Al Masri Mirna, Bader Alisa, von Schau Natascha
Institute for Medical Management and Health Sciences, Project office of the Medical Campus Upper Franconia, University of Bayreuth, Bayreuth, Germany.
Faculty of Life Sciences: Food, Nutrition, and Health, University of Bayreuth, Kulmbach, Germany.
Prev Med Rep. 2024 Dec 26;49:102959. doi: 10.1016/j.pmedr.2024.102959. eCollection 2025 Jan.
HAPpEN aims to implement and evaluate a holistic general practitioner-centered, interdisciplinary obesity management strategy in rural Germany, focusing on feasibility, health outcomes, and economic benefits.
HAPpEN is a 12-month, pragmatic single-arm, multicenter trial, informed by a formative survey, and initiated in April 2023 with 98 obese participants (body mass index, BMI ≥ 30 kg/m) in Kulmbach, Germany. The program integrates nutritional counseling, physical activity, and behavior change techniques, including smartphone-based self-monitoring. Monthly consultations help set personalized goals using a multi-stage grading scale. Primary outcomes include BMI, body weight, waist circumference, heart rate, blood pressure and parameters, while secondary outcomes assess quality of life, wellbeing, health literacy, social interaction, and digital therapy support.
The baseline cohort (mean age: 46.9 ± 11.8 years, 74.1 % female) exhibited high obesity rates (mean BMI: 40.1 ± 6.1 kg/m), with 48.5 % classified as grade III obese. Common comorbidities were hypertension (51.8 %), dyslipidemia (30.5 %) and diabetes (21.8 %). Chronic joint paint, mainly in the knees and hips, affected up to 82.4 %. A familial aggregation of obesity, diabetes, and cardiovascular diseases was noted, alongside behavioral challenges such as lack of physical activity (81.8 %) and unhealthy eating habits (56.8 %).
HAPpEN addresses obesity's multifactorial nature through general practitioner-led, community-based, and digital strategies to promote sustainable lifestyle changes in rural areas. The trial aims to inform primary care obesity management guidelines, focusing on improving health literacy, patient engagement, and long-term clinical benefits. German Clinical Trials Register: DRKS00033916.
HAPpEN旨在在德国农村地区实施并评估一项以全科医生为中心的整体跨学科肥胖管理策略,重点关注可行性、健康结果和经济效益。
HAPpEN是一项为期12个月的务实单臂多中心试验,以一项形成性调查为依据,于2023年4月在德国库尔姆巴赫启动,有98名肥胖参与者(体重指数,BMI≥30kg/m)。该项目整合了营养咨询、体育活动和行为改变技术,包括基于智能手机的自我监测。每月的咨询会使用多阶段分级量表帮助设定个性化目标。主要结果包括BMI、体重、腰围、心率、血压及参数,而次要结果评估生活质量、幸福感、健康素养、社会互动和数字疗法支持。
基线队列(平均年龄:46.9±11.8岁,74.1%为女性)呈现出较高的肥胖率(平均BMI:40.1±6.1kg/m),48.5%被归类为III级肥胖。常见的合并症有高血压(51.8%)、血脂异常(30.5%)和糖尿病(21.8%)。慢性关节疼痛,主要发生在膝盖和臀部,高达82.4%的人受影响。注意到肥胖、糖尿病和心血管疾病存在家族聚集性,同时存在行为挑战,如缺乏体育活动(81.8%)和不健康的饮食习惯(56.8%)。
HAPpEN通过全科医生主导、基于社区和数字化的策略解决肥胖的多因素性质,以促进农村地区可持续的生活方式改变。该试验旨在为初级保健肥胖管理指南提供信息,重点是提高健康素养、患者参与度和长期临床效益。德国临床试验注册:DRKS00033916。